Isotope-labeled dihydroneopterin 3'-triphosphate with 3H at positions C-l ' and C-2', respectively, has been prepared from isotope-labeled glucose as starting material. Glucose was first converted enzymatically to ribose 5-phosphate. GMP was subsequently obtained by the action of phosphoribosylpyrophosphate sy nthetase and guanosine phosphoribosyl transferase. It was subsequently phosphorylated to GTP in two steps using adenylate kinase and guanylate kinase. Dihydroneopterin triphosphate was prepared from GTP by the action of recombinant GTP-cyclohydrolase I from Escherichia coli. The method allows the incorporation of 3H and 14C isotope labels into any desired position of dihydroneopterin triphosphate. Rapid purfication procedures for phosphoribosylpyrophosphate synthetase and guanosine phosphoribosyl transferase as well as HPLC assays for their determinations are described.
Introduction
Tetrahydrobiopterin (4) serves as cofactor for the hydroxylation of aromatic amino acids in vertebrates and is thus involved in the biosynthesis of catecholamine type neurotransmitters [for review see (1) ]. Genetic defects of the tetrahydrobiopterin pathway are accompanied by severe neurological disorders in humans. More recently, it was shown that tetrahydrobiopterin also serves an immunological role in the modulation of T-cell activation by interleukin 2 [for review see (2) ] . \) This work was supported b y grants fro m the De utsche Forschungsgemeinschaft and the Fonds d er Chcmischen Industrie . 2) Author to whom correspondence should be addressed . Abreviations: DTE, dithioerythritol ; GPRT, guanine phosphoribosyl transferase; HPLC, high performa nce liquid chromatography; PRPP, phosphoribosylpyrophosphate; P EG, polye thylene glycol. Enzymes: Adenylate kinase (EC 2.7.4.3), glucose 6-phospha te dehydrogenase (EC 1.1.1.49), GTP-cyclohydro lase I (EC 3.5.4.16), guanine-phosphoribosyltransferase (EC 2.4.2. -), guanylate kinase (EC 2.7.4.8), ph ospha tase, alkaline (EC 3.1.3.1), 6-phosphogluconate dehydrogenase (EC 1.1.1.44), phosphoriboisomerase (EC 5.1.3.6), phosphoribosylpyrophosphate synthetase (EC 2.7.6.1)
The biosynthetic details of the tetrahydrobiopterin pathway have been unraveled only recently. It is well established that the first biosynthetic step is the formation of dihydroneopterin triphosphate (2) from GTP (1) by the enzyme, GTP cyclohydrolase I (1). Traditionally, it had been assumed th a t dihydroneopterin triphosphate is further converted to the dihydropteridine derivative, sepiapterin. It was hypothesized that sepiapterin is reduced to the tetrahydropterin level by the action of dihydrofolate reductase. However, this model had to be abandoned when Nichol and his coauthors found that the de novo biosynthesis of tetrahydrobiopterin does not require dihydrofolate reductase activity (1, 3) .
Several laboratories subsequently provided evidence indicating tha t the reduction of the pteridine ring to the tetrahydro level occurs early in the biosynthetic process (4 -6) . These experiments led to the establishment of pyruvoyltetrahydropterin (3) as the intermediate formed from dihydroneopterin triphosphate (2) . Pyruvoyltetrahydropterin synthase was purified to homogeneity from human liver (6) . Curtius and his coworkers could establi sh that the enzyme cata- Iyzes the release of triphosphate from 2 in a complex reaction involving a tautomerization which results in the (formal) reduction of the dihydropteridine to the tetrahydropteridine level at the expense of the side chain which is (formally) oxydized (6, 7).
3H-Iabeled 2 can be used as substrate for the quantitative assessment of pyruvoyltetrahydropterin synthase (8) . Moreover, the labeled substrates can be used for studies on the unusual reaction mechanism of this enzyme (9) .
This report describes a general method for the preparation of isotope-labeled dihydroneopterin 3' -triphosphate. Starting from appropriately labeled glucose or guanine, 14C and JH can be incorporated specifically into any desired position of the molecule.
Material and Methods

Enzymes
GTP cyc1ohydrolase I was purified from a recombinant strain of Escherichia coli as described earlier (10, 11 Assay mixtures contained 50 mM potassium phosphate pH 7.6, 2 mM dithiothreitol (DTE), 7.5 mM MgS0 4 , 3.0 mM ribose 5-phosphate, 3.0 mM ATP, and protein in a total volume of 100 Ill. Assays were incubated for 1 h at 37 'T and were terminated by heating for 2 min in a boiling water bath. AMP produced was monitored by HPLC using a column of Nuc1eosil 10 C I8 (4 x 250 mm) with an eluent containing 30 mM formic acid (flow rate, 1 ml /min). The eluate was monitored photometrically (254 nm) . The retention volume of AMP was 13.5 ml. One unit of the enzyme catalyzes the formation of 1 Ilmol of AMP per min .
Assay of G P RT synthetase
Assay mixtures contained 66.5 mM triethanolamine, 95 mM KCI , 66.5 mM K 2 HP0 4 , pH 7.6, 1.5 mM MgS0 4 , 3.5 mM PRPP, 2.5 mM guanine hydrochloride, and protein in a total volume of 60 Ill. Assays were incubated at 37 "C for 1 h . The reaction was terminated by heating for 2 min in a boiling water bath. GMP was monitored by HPLC using a column of Nucleosil 10 C I 8 (4 x 250 mm) and an eluent containing 30 mM formic acid (flow rate, 1 ml /min) . The retention volume of GMP was 9.5 ml.
Purification of P RP P synthetase
The recombinant strain Escherichia coli HO 561 (courtesy of Drs. R. Switzer and B. Hove-lensen) was grown aerobica lly in a medium containing per liter: peptone, 10 g; yeast extract, 5 g; NaCI, 10 g; ampicillin, 80 mg. Cells were harvested by centrifugation and stored at -20°C. PRPP synthetase was purified by a modification of the procedure of Swi tzer and Gi bson (12) as follows .
Frozen bacterial cells (50 g) were thawed in 100 ml of buffer containing 50 mM potassium phosphate pH 7.6. The cells were disrupted by ultrasonic treatment. The suspension was centrifuged, and the supernatant was dialyzed overnight against 50 mM phosphate buffer pH 7.6 containing 2 mM DTE. A 10% solution of streptomycin sulphate (10 ml) was added to the dialyzed crude cell extract with stirring. The suspension was then heated to 54°C within 5 min. The flask was transferred to a 55 D C water bath and kept at 55 °C for exactly 5 min. The solution was quickly cooled to 4 °C in an ice bath and centrifuged at 23000 g for 60 min at 4 0c. To the clear supernatant (96 ml), 22.7 g of (NH4)2S04 were added (40% saturation). The solution was incubated for 2 h at room temperature and subsequently centrifuged at 23000 g for 60 min. The precipitate was dissolved in 200 ml of 50 mM phosphate buffer, pH 7.6 containing 2 mM DTE, 1 mM MgS0 4 , and 25% (NH 4 hS04' The solution was dialyzed against 50 mM phosphate buffer, pH 7.6, containing 2 mM DTE. It was subsequently placed on a column of DEAE cellulose DE 52 (2.5 x 30 cm). The column was developed with 240 ml of phosphate buffer, pH 7.6, containing 2 mM DTE followed by a linear gradient of 0-200 mM KCl in 50 mM phosphate buffer pH 7.6 containing 2 mM DTE.
Fractions were pooled and concentrated by dialysis against 20% PEG. The partially purified enzyme had a specific activity of 9.0 U /mg.
Pur(fication of GPRT
Escherichia coli DSM 613 was grown with aeration in a medium supplemented with amethopterin as described by Hochstadt (13) . Cells were harvested by centrifugation and stored at -20°C. Preparation of cell extract and chromatography on DEAE cellulose was performed as described above. The partially purified enzyme had a specific activity of 0.25 U /mg and was stored in liquid nitrogen.
Preparation of 3 H-labeled dihy droneopterin 3' -triphosphate
Ribose 5-phosphate -Reaction mixtures contained 0.55 mM glucose labeled with ' H at C-4 or C-5, 50 mM Tris hydrochloride, pH 7.9, 5.8 mM MgC\z, 5. GMP -The reaction mixture contained 3H-labeled ribose 5-phosphate from the previous step, 40 mM phosphate, pH 7.5, 4.7 mM MgS0 4 , 0.52 mM guanine hydrochloride, 0.42 mM ATP, 0.24 units of PRPP synthetase and 0.08 units of GPRT in a total volume of 480 f.l\. The mixture was incubated for 45 min at 37 ~c. The reaction was terminated by heating in a boiling waterbath for 2 min and centrifuged. The supernatant was passed through a HPLC column of Nucleosill00 CIS (4 x 250 mm). The eluent contained 30 mM formic acid and 50 mM ammonium formate. The flow rate was 0.5 ml/min. The effluent was monitored photometrically (254 nm). The retention volume of GMP was 12.4 m\. The fractions containing GMP were evaporated to dryness under reduced pressure. HPLC chromatography was repeated using 30 mM formic acid as eluent (flow rate, 0.5 ml/min; retention volume, 9.5 ml). The fraction containing GMP was concentrated to dryness under reduced pressure.
GTP -The reaction mixture contained 4 nmol eH]GMP from the previous step, 68 mM Tris hydrochloride, pH 7.9 , 34 f.lM ATP, 1.35 mM phosphoenol pyruvate, 34 mM MgCh, 34 mM KCl, 6.8 mM dithioerythritol, 10 units of pyruvate kinase and 0.2 units of guanylate kinase in a total volume of 148 f.ll (14) . The mixture was incubated at 37 "C for 100 min. It was subsequently passed through an anion exchange HPLC column (SB 10, Macherey-Nagel, Duren, 4 x 250 mm). The eluent was 0.15 M NH4H C0 3 containing 20% methanol (flow rate, 1.5 ml/min). The effluent was monitored photometrically (254 nm). The retention volume of GTP was 71 m!. The fraction containing GTP was lyophilized (2 mTorr) and stored at -70°C. The radiochemical yield was 8% based on glucose. Dihydroneopterin triphosphate -The reaction mixture contained 9.5 J..lM 3H-labeled GTP, 35 mM Tris hydrochloride, pH 7.4, 3.0 mM DTE, 0.7 mM MgCI 2 , and 0.3 units of GTP cyclohydrolase I in a total volume of 127 J..ll. The mixture was incubated at 37°C for 1 h and passed through a Millipore filter. The solution could be stored for several months at -70°C without substantial decomposition.
Conversion of dihydroneopterin 3' -triphosphate to neopterin
To an aliquot of a dihydroneopterin triphosphate solution (25 J..ll), 0.2 U of alkaline phosphatase was added and the mixture was incubated at 37°C for 30 min (9) . Subsequently, 50 J..ll of a solution containing 2% KI and 1 % 12 in 0.2 M trichloroacetic acid were added, and the mixture was kept for 30 min at room temperature in the dark. Subsequently, 10 J..ll of a 2% solution of ascorbic acid were added. The mixture was passed through a HPLC column of Nucleosil 100 C I8 (4 x 250 mm). The eluent contained 30 mM formic acid. Elution was monitored fluorometrically. The fraction containing neopterin (10) was evaporated to dryness under reduced pressure.
Permanganate degradation of neopterin
To a solution of neopterin (10, 500 J..l1) containing 30 mM HCOOH and 30 mM ammonium formate (obtained by HPLC separation), 10 mg of KMn04 dissolved in 50 J..l1 of 1 M NaOH were added (15 formic acid and 30 mM ammonium formate).
Periodate degradation of neopterin
To a solution containing neopterin, 30 mM formic acid and 30 mM ammonium formate (0.5 ml), 10 mg of KI0 4 dissolved in 50 J..ll of water were added, and the mixture was kept at room temperature for 20 min. NaBH4 (2.5 mg) was added, and the mixture was kept for 15 min at room temperature. 6-Hydroxymethylpterin (11) was isolated by reversed phase HPLC (column, Nucleosill00 C 1S ; eluent, 30 mM formic acid and 30 mM ammonium formate).
Results and Discussion
The chemical synthesis of dihydroneopterin 3' -triphosphate has been reported (16) . However, it would appear difficult to prepare isotope-labeled derivatives of high specific activity by existing protocols for chemical synthesis. We were interested in a general protocol which allows the introduction of 3H or 14C to virtually any position of 2 at high specific activity. This aim can be achieved by a sequence of enzyme reactions starting from D-glucose (5) as the isotopelabeled precursor (Fig. 2) . Glucoses with virtually all desired labeling patterns are commercially available.
The enzymes required for the sequence of reactions in Figure 2 are commercially available with the exception of PRPP synthetase, GPRT, and GTP cyclohydrolase I. We purified PRPP synthetase from a strain of Escherichia coli carrying a plasmid with the gene for PRPP synthetase which was kindly provided by R. L. Switzer and B. Hove-Jensen. The enzyme was partially purified from cell extract of this organism by the procedure described under Methods.
The preparation of GPRT has been reported by Hochstadt (13) . However, we found it difficult to use her method. We subsequently developed a method for the partial purification of the enzyme by chromatography on DEAE cellulose as described under Methods.
It should be mentioned that we found it difficult to measure the activity of both GPRT and PRPP synthetase in crude cell extracts by published procedures. This prompted us to develop HPLC methods for the detection of the reaction products as described under Methods. The reported assay of PRPP synthetase is based on the HPLC detection of AMP which is formed from ATP as the second reaction product. GPRT was monitored by direct HPLC analysis of GMP.
GTP Cyclohydrolase I was purified from a strain of Escherichia coli carrying the plasmid pCYH which contains the gene coding for the enzyme and allows the 100-fold overexpression of the protein (11).
The enzymatic synthesis of ribose phosphate (6) from glucose is well established, and procedures for the preparation of mol quantities have been reported (17) . In order to prepare ribose phosphate of the highest possible specific activity, it was essential to optimize the reaction mixture for a small amount of substrate (approximately 10 nmol of glucose). This could be achieved by a one pot reaction yielding 6 from glucose as described under Methods. ex-Ketoglutarate and glutamate dehydrogenase were included in the reaction mixtures in order to reoxidize NADPH. The product was isolated by ion exchange chromatography.
The conversion of ribose 5-phosphate to GMP (7) by the enzymes PRPP synthetase and GPRT was performed in a single reaction step. The product, GMP, was isolated by HPLC procedures. As a consequence of the small amounts of product which were essential in order to obtain maximum specific activity, the purification procedure could be performed on analytical HPLC columns.
GMP was converted enzymatically to GTP (1) by phosphorylation in two steps using phosphoenol pyruvate and ATP as phosphate donors. The product was isolated by anion exchange chromatography on an analytical scale HPLC column. It was essential to obtain GTP of high purity in order to avoid difficulties with the reaction catalyzed by GTP cyclohydrolase. The radiochemical yield of GTP was 8% based on the starting material, glucose. The specific activity was virtually undiluted by comparison with the commercially supplied glucoses which served as starting material.
GTP was converted to dihydroneopterin triphosphate (2) by the action of highly purified GTP cyclohydrolase I. The reaction was essentially quantitative. No purification was necessary, and the reaction mixture could be used directly for subsequent experiments. It can be stored at -70 D C for periods of several weeks without significant loss of dihydroneopterin triphosphate (8) . In order to monitor the amount of product formed, 2 can be oxidized to neopterin triphosphate (8) which can be detected with high sensitivity by fluorescence-monitored anion exchange chromatography. It is also possible to remove the phosphate residues by treatment with phosphatase. The resulting neopterin (10) is then determined by reversed phase HPLC.
It should be noted that the preparation of GTP cyclohydrolase I used in this study contains small amounts of GTP which invariably lead to some dilution of the radioactive substrate. It is therefore necessary to monitor the specific activity of 2 by conversion to 10 which is isolated by HPLC.
For studies on the mechanism of pyruvoyl tetrahydropterin synthase, it was relevant to assess unequivocally the position of the label in the 3H-Iabeled dihydroneopterin used. This could be achieved by conversion of dihydroneopterin triphosphate to neopterin (10) which is then degraded by periodate yielding 6-formylpterin (12) which is further converted to 6-hydroxymethylpterin (11) by reduction with NaBH4 (Fig. 3) . Alternatively, neopterin is converted to pterin 6-carboxylic acid (2) by treatment with alkaline permanganate. 11 retains the l ' -hydrogen of dihydroneopterin triphosphate. On the other hand, all side chain hydrogen atoms are removed by permanganate oxidation to 9. By this approach, we could confirm that 2 derived from [4-3 H]glucose is exclusively labeled at position 1'. We could also show that [5-3 H]glucose yields 2 which carries no label at the l ' -position.
[1 ' -3H]_2 and [2' -3H]-2 prepared as described in this paper have been utilized to determine isotope effects for the breaking of the C-H bonds at C-l' and C-2' in the reaction catalyzed by pyruvoyltetrahydropterin synthetase. The results of these experiments have been published earlier (9) .
The release of tritium as tritiated water can be used as a sensitive and specific assay for pyruvoyl-tetrahydropterin synthase (8) . In principle, 2 labeled at position l' or 2' could both be utilized for this assay. However, in light of the larger isotope effect observed with the l ' -labeled substrate, it is preferable in terms of sensitivity to use [2 '-3H]NH 2 TP for the enzyme assay. This method has been used for the determination of pyruvoyltetrahydropterin synthase activity in cultured cells under a variety of experimental conditions (8, 18 -21) .
In the present study, the synthetic method described has been applied for the labeling of the hydrogen atoms at position l' and 2' of 2. However, with appropriately labeled glucose precursors, any carbon or hydrogen atom in the side chain as well as the pyrazine ring can be labeled specifically. Moreover, the method can also be used to label the pyrimidine atoms of 2 using appropriately labeled guanine as precursor.
